XML 38 R36.htm IDEA: XBRL DOCUMENT v3.3.0.814
Stock-Based Compensation Outstanding Options and SSARs (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Options / SSARs outstanding at beginning of period     7,004    
Incentive shares granted     379    
Options / SSARs exercised     (1,141)    
Options / SSARs canceled     (307)    
Options / SSARs outstanding at end of period 5,935   5,935    
Options / SSARs outstanding Weighted Average Exercise Price $ 14.29   $ 14.29   $ 14.19
Options / SSARs granted Weighted Average Exercise Price 17.04   17.04    
Options / SSARs exercised Weighted Average Exercise Price 11.45   11.45    
Options / SSARs canceled Weighted Average Exercise Price $ 25.83   $ 25.83    
Options / SSARs outstanding Weighted Average Contractual Term (in years)     4 years 6 months    
Options / SSARs outstanding Aggregate Intrinsic Value (in millions) $ 19.5   $ 19.5    
Vested and expected to vest [1] 5,638   5,638    
Vested and expected to vest Aggregate Intrinsic Value (in millions) [1] $ 18.5   $ 18.5    
Options / SSARs exercisable 5,183   5,183    
Options / SSARs exercisable Weighted Average Exercise Price $ 13.78   $ 13.78    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term     3 years 9 months 18 days    
Options / SSARs exercisable Aggregate Intrinsic Value (in millions) $ 19.5   $ 19.5    
Options and SSARs [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Weighted-average period of years costs are expected to be recognied over     1 year 6 months    
Compensation Expense 0.8 $ 0.9 $ 2.7 $ 2.8  
Unrecognized compensation costs $ 4.7   $ 4.7    
Number of Shares Available for Grant 3,900   3,900    
Stock Appreciation Rights (SARs) [Member]          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]          
Vesting Period     3 years    
[1] Options and SSARS expected to vest based upon historical forfeiture rate